Roquette will operate Biosuccinium plant after DSM leaves Reverdia to focus on the role of exclusive licensor




Type of post: NEWS IN BRIEF.

In June 2010, DSM and Roquette established a JV named Reverdia, for the production, commercialization and market development of Biosuccinium™, sustainable succinic acid. In May 2011, Reverdia announced the construction of a large-scale plant for the production of succinic acid from renewable resources plant in Cassano Spinola (Italy). The 10,000 tons/y facility commenced operations in December 2012 basing its production on an integrated biorefinery concept.

Now, Reverdia´s parent companies have decided on a strategic shift in the continuing operations of their JV. Effective 1 April 2019, it will be dissolved and the partners will transfer the rights and obligations related to the Cassano biorefinery to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium. Customer service, order processing, the marketing and the sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, which is the original developer of the Biosuccinium technology, will assume the role of exclusive licensor in line with its business model in this field.

Popular Posts

Hydrotreating (HVO) – Advantages over FAME and properties

Biorrefinerías de ácido levulínico

Fotobiorreactores

Biobased adipic acid

Biorrefinerías de ácido succínico